NCT06961669 2025-05-29
ECAR01
Anhui Provincial Hospital
Phase NA Recruiting
Clinical Trials
5 trialsNCT05648019 2023-03-09
CD19-Directed Chimeric Antigen Receptor (CAR) T-Cell Therapy for Relapsed/Refractory B-Lineage Leukaemia / Lymphoma - A Feasibility Protocol
KK Women's and Children's Hospital
Phase 2 Recruiting
NCT05137860 2022-01-18
Efficacy of the Use of Bortezomib for the Treatment of Relapsed Leukemia or Positive MRD
Hospital General de Mexico
Phase 4 Unknown
NCT00342316 2020-01-27
Reduced Intensity Conditioning Transplantation Versus Standard of Care in Acute Myeloid Leukemia
Vastra Gotaland Region
Phase NA Completed
NCT03881774 2019-03-21
Cord Blood Derived CAR-T Cells in Refractory/Relapsed B Cell Malignancies
Henan Cancer Hospital
Phase 1 Unknown